CN102549432B - 用于软组织疾病诊断和作为口腔护理干预的治疗性靶标的蛋白质生物标记 - Google Patents

用于软组织疾病诊断和作为口腔护理干预的治疗性靶标的蛋白质生物标记 Download PDF

Info

Publication number
CN102549432B
CN102549432B CN201080015874.4A CN201080015874A CN102549432B CN 102549432 B CN102549432 B CN 102549432B CN 201080015874 A CN201080015874 A CN 201080015874A CN 102549432 B CN102549432 B CN 102549432B
Authority
CN
China
Prior art keywords
mmp
biomarker
biomarkers
sample
periodontal disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080015874.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN102549432A (zh
Inventor
H·M·特里维迪
徐韬
杨英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CN102549432A publication Critical patent/CN102549432A/zh
Application granted granted Critical
Publication of CN102549432B publication Critical patent/CN102549432B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201080015874.4A 2009-04-01 2010-04-01 用于软组织疾病诊断和作为口腔护理干预的治疗性靶标的蛋白质生物标记 Expired - Fee Related CN102549432B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01
US61/165674 2009-04-01
PCT/US2010/029674 WO2010115034A2 (en) 2009-04-01 2010-04-01 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Publications (2)

Publication Number Publication Date
CN102549432A CN102549432A (zh) 2012-07-04
CN102549432B true CN102549432B (zh) 2015-03-25

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080015874.4A Expired - Fee Related CN102549432B (zh) 2009-04-01 2010-04-01 用于软组织疾病诊断和作为口腔护理干预的治疗性靶标的蛋白质生物标记

Country Status (15)

Country Link
US (1) US8753820B2 (enExample)
EP (1) EP2414837B1 (enExample)
JP (1) JP5643288B2 (enExample)
CN (1) CN102549432B (enExample)
AR (1) AR076041A1 (enExample)
BR (1) BRPI1013184A2 (enExample)
CA (1) CA2753718C (enExample)
CO (1) CO6430490A2 (enExample)
MX (1) MX2011008439A (enExample)
MY (1) MY179250A (enExample)
RU (1) RU2523383C2 (enExample)
SG (1) SG173461A1 (enExample)
TW (1) TWI481870B (enExample)
WO (1) WO2010115034A2 (enExample)
ZA (1) ZA201106056B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI405565B (zh) * 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗－骨質流失及抗－牙周附連喪失之功效
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
WO2018129043A1 (en) * 2017-01-03 2018-07-12 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
JP7486316B2 (ja) 2017-05-24 2024-05-17 コーニンクレッカ フィリップス エヌ ヴェ 唾液のｉｌ－１ベータ及びｍｍｐ－９に基づく軽度の又は進行した歯周炎の診断
EP3631458A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of periodontitis based on salivary hgf and mmp-8
WO2018215596A1 (en) * 2017-05-24 2018-11-29 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
WO2019084351A1 (en) 2017-10-27 2019-05-02 The Regents Of The University Of California SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005103071A1 (en) * 2004-04-23 2005-11-03 Ctt Cancer Targeting Technologies Oy Peptide inhibitors of metalloproteinase activity

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
EP0935454B1 (de) 1996-06-12 2001-08-22 Cognis Deutschland GmbH Kosmetische und/oder pharmazeutische zubereitungen
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
WO2001048481A1 (en) 1999-12-03 2001-07-05 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
WO2001078652A2 (en) 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
TW200902047A (en) 2003-02-14 2009-01-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
WO2005039504A2 (en) 2003-10-24 2005-05-06 Eisai Co., Ltd. Compounds and methods for treating toll-like receptor 2-related diseases and conditions
US20070212686A1 (en) 2003-12-03 2007-09-13 Whitehead Institute For Biomedical Research Use Of T-Cadherin As A Target
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
WO2006068133A1 (ja) * 2004-12-21 2006-06-29 National University Corporation NARA Institute of Science and Technology Ｎｆａｔ２発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
RU2431845C2 (ru) * 2006-01-10 2011-10-20 Колгейт-Палмолив Компани Способы модулирования рецепторов клеточных поверхностей для предотвращения или снижения воспаления
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005103071A1 (en) * 2004-04-23 2005-11-03 Ctt Cancer Targeting Technologies Oy Peptide inhibitors of metalloproteinase activity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Effect of meloxicam on gingival crevicular fluid IL-1beta and IL1 receptor antagonist levels in subjects with chronic periodontitis, and its effects on clinical parameters;Toker等;《Clinical Oral Investigations》;20061231;第10卷(第4期);摘要 *
Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patient;Pozo等;《JOURNAL OF PERIODONTAL RESEARCH》;20050630;第40卷(第3期);200页，图1 *
Prostaglandin production by human gingival fibroblasts inhibited by triclosan in the presence of cetylpyridinium chloride;Kim等;《Journal of Periodontology》;20051031;第76卷(第10期);1736页，图4-5 *
盐酸米诺四环素软膏对龈沟液中白细胞介素-8的影响;秦念红等;《武汉大学学报(医学版)》;20060131;第27卷(第1期);75-78页 *

Also Published As

Publication number Publication date
RU2523383C2 (ru) 2014-07-20
CO6430490A2 (es) 2012-04-30
WO2010115034A2 (en) 2010-10-07
US20120028261A1 (en) 2012-02-02
CN102549432A (zh) 2012-07-04
BRPI1013184A2 (pt) 2016-04-12
AR076041A1 (es) 2011-05-11
EP2414837A2 (en) 2012-02-08
ZA201106056B (en) 2015-05-27
US8753820B2 (en) 2014-06-17
AU2010232593A1 (en) 2011-08-25
TW201102653A (en) 2011-01-16
MY179250A (en) 2020-11-02
SG173461A1 (en) 2011-09-29
WO2010115034A3 (en) 2010-12-29
JP2012522994A (ja) 2012-09-27
JP5643288B2 (ja) 2014-12-17
TWI481870B (zh) 2015-04-21
EP2414837B1 (en) 2015-06-03
RU2011144032A (ru) 2013-05-10
MX2011008439A (es) 2011-09-06
CA2753718C (en) 2015-06-23
CA2753718A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
CN102549432B (zh) 用于软组织疾病诊断和作为口腔护理干预的治疗性靶标的蛋白质生物标记
Ozmeric Advances in periodontal disease markers
Maldonado et al. Citrullination in periodontium is associated with Porphyromonas gingivalis
Lönn et al. High concentration but low activity of hepatocyte growth factor in periodontitis
Guentsch et al. Variables of host response in saliva of patients with periodontitis: a pilot study.
Tüter et al. Short term effects of non-surgical periodontal treatment on gingival crevicular fluid levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in patients with chronic and aggressive periodontitis
CN102365550B (zh) 口腔组合物的抗骨丢失和抗附着丧失作用
Ahmed et al. Matrix metalloproteinase activity in gingival crevicular fluid and periodontal health status in Down syndrome patients: A comparative study
AU2010232593B2 (en) Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention
Nair et al. Estimation of soluble Triggering Receptor Expressed on Myeloid cells-1 (sTREM-1) and its influence on expression of IL-10 in Periodontal Health and Disease
HK1167272B (en) Anti bone-loss and anti attachment-loss effects of an oral composition
Sharikadze-Balaban et al. FEATURES OF THE CLINICAL COURSE OF GENERALIZED PERIODONTITIS IN WOMEN OF REPRODUCTIVE AGE WITH POLYCYSTIC OVARY SYNDROME
Shaimaa et al. The profile of tooth and gingival crevicular fluid matrix metalloproteinase-1 in different dental diseases
Jha Estimation and Correlation of Salivary Human Beta-Defensin-2 and Interleukin-1 Beta Expression Profiles in Chronic Periodontitis: A Cross Sectional Study
Gogoi Effect of Scaling and Root Planing on Gingival Crevicular Fluid Levels of Matrix Metalloproteinase 8 (MMP 8) and Periodontal Inflammed Surface Area (Pisa) Among Chronic Periodontitis Patients
Shivamanjunath Role of GCF As Potential Biomarker in the Diagnosis of Periodontal Disease
Ng Association of salivary biomarkers with alveolar bone loss

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150325

Termination date: 20160401

CF01 Termination of patent right due to non-payment of annual fee